Detalles de la búsqueda
1.
Molecular Characterization and Inhibition of a Novel Stress-Induced Mitochondrial Protecting Role for Misfolded TrkAIII in Human SH-SY5Y Neuroblastoma Cells.
Int J Mol Sci
; 25(10)2024 May 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-38791513
2.
Doxorubicin-Induced TrkAIII Activation: A Selection Mechanism for Resistant Dormant Neuroblastoma Cells.
Int J Mol Sci
; 23(18)2022 Sep 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-36142807
3.
A Prospective Study of Intraarterial Infusion Chemotherapy in Advanced Wild-Type BRAF Melanoma Patients.
J Surg Res
; 268: 737-747, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34253376
4.
Multidisciplinary Treatment, Including Locoregional Chemotherapy, for Merkel-Polyomavirus-Positive Merkel Cell Carcinomas: Perspectives for Patients Exhibiting Oncogenic Alternative Δ exon 6-7 TrkAIII Splicing of Neurotrophin Receptor Tropomyosin-Related Kinase A.
Int J Mol Sci
; 21(21)2020 Nov 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33153070
5.
A Study of Alternative TrkA Splicing Identifies TrkAIII as a Novel Potentially Targetable Participant in PitNET Progression.
Biology (Basel)
; 13(3)2024 Mar 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38534441
6.
Nutraceutical Preventative and Therapeutic Potential in Neuroblastoma: From Pregnancy to Early Childhood.
Life (Basel)
; 12(11)2022 Nov 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36362917
7.
Mechanisms involved in selecting and maintaining neuroblastoma cancer stem cell populations, and perspectives for therapeutic targeting.
World J Stem Cells
; 13(7): 685-736, 2021 Jul 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-34367474
8.
Hypoxia-induced alternative splicing: the 11th Hallmark of Cancer.
J Exp Clin Cancer Res
; 39(1): 110, 2020 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32536347
9.
Discovery, characterization and potential roles of a novel NF-YAx splice variant in human neuroblastoma.
J Exp Clin Cancer Res
; 38(1): 482, 2019 Dec 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31805994
10.
A pilot study of alternative TrkAIII splicing in Merkel cell carcinoma: a potential oncogenic mechanism and novel therapeutic target.
J Exp Clin Cancer Res
; 38(1): 424, 2019 Oct 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-31640749
11.
TrkAIII signals endoplasmic reticulum stress to the mitochondria in neuroblastoma cells, resulting in glycolytic metabolic adaptation.
Oncotarget
; 9(9): 8368-8390, 2018 Feb 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29492201
12.
The oncogenic neurotrophin receptor tropomyosin-related kinase variant, TrkAIII.
J Exp Clin Cancer Res
; 37(1): 119, 2018 Jun 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-29914559
13.
TRAIL induces pro-apoptotic crosstalk between the TRAIL-receptor signaling pathway and TrkAIII in SH-SY5Y cells, unveiling a potential therapeutic "Achilles heel" for the TrkAIII oncoprotein in neuroblastoma.
Oncotarget
; 7(49): 80820-80841, 2016 Dec 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-27821809
14.
Retrograde TrkAIII transport from ERGIC to ER: a re-localisation mechanism for oncogenic activity.
Oncotarget
; 6(34): 35636-51, 2015 Nov 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-26415233
15.
Gelatinase B/MMP-9 in Tumour Pathogenesis and Progression.
Cancers (Basel)
; 6(1): 240-96, 2014 Jan 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-24473089
16.
The alternative TrkAIII splice variant targets the centrosome and promotes genetic instability.
Mol Cell Biol
; 29(17): 4812-30, 2009 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-19564412
17.
Reconstitution of TIMP-2 expression in SH-SY5Y neuroblastoma cells by 5-azacytidine is mediated transcriptionally by NF-Y through an inverted CCAAT site.
Exp Cell Res
; 286(2): 209-18, 2003 Jun 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-12749850
Resultados
1 -
17
de 17
1
Próxima >
>>